If mild hypocalcemia, defined as serum calcium (adjusted for albumin) between 7.5 and 8.5 mg/dl, accounts for up to 7% of patients treated with denosumab for osteoporosis [10], the incidence is higher in patients with bone metastases. The gene discussed is ALB; the disease is Hypocalcemia.